I suspect the share price will take off with the June report or upgrade if not at some point earlier. The fact they have delayed the report bodes well as they are very busy. Resmed has a different business model, but the clear increase in demand for respiratory products bodes well for FPH, particularly acute care demand and pandemic stockpiling.
I suspect the share price will take off with the June report or...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add FPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.77 |
Change
0.010(0.04%) |
Mkt cap ! $16.21B | |||
| Open | High | Low | Value | Volume |
| $28.00 | $28.15 | $27.38 | $6.092M | 218.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280 | $27.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.91 | 488 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| FPH (ASX) Chart |